NCT01566448View on ClinicalTrials.gov

Treatment of Severe Mucositis Pain With Oral Ketamine Mouthwash

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Mucositis
Interventions
DRUG

Ketamine

20mg/5ml swish and spit four times daily

Trial Locations (1)

26506

West Virginia University Hospitals Mary Babb Randolph Cancer Center, Morgantown

All Listed Sponsors
lead

Aaron Cumpston, PharmD, BCOP

OTHER

NCT01566448 - Treatment of Severe Mucositis Pain With Oral Ketamine Mouthwash | Biotech Hunter | Biotech Hunter